Compare SLNG & XTNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SLNG | XTNT |
|---|---|---|
| Founded | 2013 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.5M | 82.6M |
| IPO Year | N/A | N/A |
| Metric | SLNG | XTNT |
|---|---|---|
| Price | $5.51 | $0.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $10.00 | $1.50 |
| AVG Volume (30 Days) | 10.7K | ★ 183.1K |
| Earning Date | 02-24-2026 | 03-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.05 | 0.01 |
| Revenue | $72,270,000.00 | ★ $133,083,000.00 |
| Revenue This Year | $7.02 | $15.08 |
| Revenue Next Year | $7.68 | N/A |
| P/E Ratio | $104.70 | ★ $54.90 |
| Revenue Growth | N/A | ★ 16.88 |
| 52 Week Low | $3.29 | $0.34 |
| 52 Week High | $8.28 | $0.95 |
| Indicator | SLNG | XTNT |
|---|---|---|
| Relative Strength Index (RSI) | 67.55 | 36.12 |
| Support Level | $4.28 | $0.60 |
| Resistance Level | $6.36 | $0.67 |
| Average True Range (ATR) | 0.38 | 0.05 |
| MACD | 0.15 | -0.01 |
| Stochastic Oscillator | 61.01 | 5.07 |
Stabilis Solutions Inc is an energy transition company that provides turnkey clean energy production, storage, transportation, and fueling solutions using liquefied natural gas (LNG) to multiple end markets. The company provides LNG solutions to customers in diverse end markets, including aerospace, agriculture, energy, industrials, marine bunkering, mining, pipeline, remote power, and utility markets. It generates revenue by selling and delivering LNG to its customers, renting cryogenic equipment, and providing engineering and field support services. It has a geographical presence in the United States and Mexico.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.